机译:miR-200a通过抑制TGF-(52表达来预防肾纤维化
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Muscle Biology and Therapeutics, Baker IDI Heart and Diabetes Institute, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
Diabetes Division, JDRF Danielle Alberti Memorial Centre for Diabetes Complications, Melbourne, Australia;
机译:miR-200a通过抑制TGF-β2表达抑制肾纤维化。
机译:miR-328通过直接靶向TGF-β2防止肾脏纤维化
机译:TGF-β1,ILK和wnt信号转导诱导人肾纤维化上皮向间质转化的差异表达:一项免疫组化研究
机译:肝细胞癌中转化生长因子-β1(TGF-β1)和TGF-β1mRNA的异常表达及其诊断价值
机译:NGF诱导的顶乳乳头干细胞TGF-β1的表达
机译:miR-200a通过抑制TGF-β2表达来预防肾纤维化
机译:miR-200a通过抑制TGF-β2表达来预防肾纤维化